We next postulated that Sox10-KD leads to comparable cell-state transitions in glioblastoma cell lines, allowing us to use Sox10-KD cells as in vitro models to evaluate therapeutic strategies for targeting the quiescent/slow-cycling state. Here, SOX10 is linked to glioblastoma.